Tissue Pro
Natural health product licensed in Canada
- Licence holder
- Natural Professional Therapeutics Inc.
- NPN or DIN-HM
- 80039926
- Status
- Active licence
- Licence date
- 14 February 2013
- Revision date
- 23 March 2014
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Sélénium: up to 200 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Potency : 2 % Caffeine | Not specified | Not calculated |
| Vitis vinifera Source : Graine(s) Extraction ratio : 4:1 Dry plant equivalent : 500 mg Potency : 80 % Oligomeric proanthocyanidins | 125 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Tagetes erecta - Fleur | 5 mg | Not calculated |
| (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol Source : Lutéine | 5 mg | Not calculated |
| Sélénium Source : Sélénométhionine | 100 mcg | 200 µg |
| Acide (±)-1,2-dithiolane-3-pentanoïque Source : Acide DL-alpha-lipoÏque | 80 mg | Not calculated |
| Ruscus aculeatus Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 200 mg | 50 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Eau purifiée, Cellulose microcristalline, Hypromellose, Huile de carthame
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Turmeric is used in Herbal Medicine as a hepato/liver protectant. Horse chestnut is used in Herbal Medicine to help treat chronic venous insufficiency and associated symptoms. Grape seed extract helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling. Lutein helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Selenium and calcium are factors in the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you have a bile duct obstruction. Do not use if you are pregnant or lactating. Do not use if you have bronchial asthma or whooping cough. Do not use if undergoing immunosuppressant therapy or if having an autoimmune disease. Do not use if you are taking health products that affect blood coagulation (i.e. Anti-platelet medication, blood thinners, digoxin, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80039926
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.